Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: A review of the literature

Rheumatology (United Kingdom)

Volumn 52, Issue 4, 2013, Pages 684-696

  Castelino, Madhura ^a   Abbott, Janice ^b   McElhone, Kathleen ^a   Teh, Lee Suan ^a  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Development; Quality of life; Systemic lupus erythematosus; Validation

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTENT VALIDITY; HUMAN; INTERNAL CONSISTENCY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY;

ADULT; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84875621427     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes370     Document Type: Article

References (35)

1. Archenholtz B, Burckhardt CS, Segesten K. Quality of life of women with systemic lupus erythematosus or rheumatoid arthritis: domains of importance and dissatisfaction. Qual Life Res 1999;8:411-6.
2. Urowitz MB, Gladman DD, Tom BDM, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008;35:2152-8.
3. McElhone K, Abbott J, Teh L-S. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-4.
4. Seawell AH, Danoff-Burg S. Psychosocial research on systemic lupus erythematosus: a literature review. Lupus 2004;13:891-9.
5. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Lupus 2000;9:322-7.
6. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM193282.pdf (29 November 2011, date last accessed).
7. Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products. 2005. http://www.ispor. org/workpaper/EMEA-HRQL-Guidance.pdf (29 November 2011, date last accessed).
8. Moore AD, Clare AE, Danoff DS et al. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices. J Rheumatol 1999;26:1285-90.
9. Gladman DD, Urowitz MB, Ong A et al. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996;5:190-5.
10. Luo N, Chew LH, Fong KY et al. Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2003;32:685-90.
11. Luo N, Chew LH, Fong KY et al. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003;12:87-92.
12. Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F. EuroQol is a useful instrument for assesing the health-related quality of life of the patients with systemic lupus erythematosus. Lupus 2005;14:334-5.
13. Thumboo J, Fong KY, Ng TP et al. Initial construct cross-cultural validation of the Short Form 36 for quality of life assessment of systemic lupus erythematosus patients in Singapore. Ann Acad Med Singapore 1997;26:282-4.
14. Rood MJ, Borggreve SE, Huizinga TWJ. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. J Rheumatol 2000;27:2057-9.
15. Terwee CB, Bot SD, de Boer MR et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42.
16. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737-45.
17. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instrument: an international Delphi study. Qual Life Res 2010;19:539-49.
18. Mokkink LB, Terwee CB, Knol DL et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010;18: 10-22.
19. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2011. http://www.springerlink.com/content/ 4555127664034526/fulltext.pdf (29 November 2011, date last accessed).
20. Stoll T, Gordon C, Seifert B et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1608-14.
21. Thumboo J, Fong KY, Leong KH, Feng PH, Thio ST, Boey ML. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999;26: 97-102.
22. Thumboo J, Feng PH, Boey ML, Soh CH, Thio S, Fong KY. Validation of the Chinese SF-36 for quality of life assessment in patients with systemic lupus erythematosus. Lupus 2000;9:708-12.
23. Burckhardt CS, Archenholtz B, Bjelle A. Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the quality of life scale (QOLS). Scand J Rheumatol 1992;21: 190-5.
24. Aggarwal R, Wilke CT, Pickard AS et al. Psychometric properties of EuroQol 5D and Short Form 6D in patients with SLE. J Rheumatol 2009;36:1209-16.
25. Grootscholten C, Ligtenberg G, Derksen RH et al. Health related quality of life in systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003;12:635-44.
26. Freire EA, Guimaraes E, Maia I, Ciconelli RM. Systemic lupus erythematosus symptom checklist: cross-cultural adaptation to Brazilian Portuguese language and reliability evaluation. Acta Reumatol Port 2007;32:341-4.
27. Leong KP, Kong KO, Thong BY et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 2005;44:1267-76.
28. Kong KO, Ho HJ, Thong BY et al. Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum 2007;57: 980-5.
29. Freire EA, Bruscato A, Leite DR, Sousa TT, Ciconelli RM. Translation into Brazilian Portuguese, cultural adaptation and validation of the systemic lupus erythematosus quality of life questionnaire (SLEQOL). Acta Reumatol Port 2010; 35:334-9.
30. McElhone K, Abbott J, Shelmerdine J et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Care Res 2007;57:972-9.
31. Jolly M, Pickard AS, Wilke C et al. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis 2010;69:29-33.
32. Doward LC, McKenna SP, Whalley D et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68: 196-200.
33. Likert R. A technique for the development of attitude scales. Educ Psychol Measure 1952;12:313-5.
34. Burckhardt CS, Anderson KL, Archenholtz B, Hagg O. The Flanagan Quality of Life Scale: evidence of construct validity. Health Qual Life Outcomes 2003; 1:59.
35. Burckhardt CS, Woods SL, Schultz AA, Ziebarth DM. Quality of life of adults with chronic illness: a psychometric study. Res Nurs Health 1989;12:347-54.